Eden Brew
Eden Brew is a Melbourne-based precision fermentation company producing animal-free recombinant beta-casein protein via engineered yeast. It supplies the DeepForte™ B2B casein micelle platform to food and supplement manufacturers in Australia and New Zealand for slow-release nutrient delivery.
- Company typePrivate
- Founded2021
- HeadquartersSydney, Australia
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Eden Brew does
Eden Brew is an Australian precision fermentation food technology company that produces animal-free dairy proteins using engineered yeast. Founded in 2021 in Melbourne as a spin-out of CSIRO research, with Norco Dairy Co-operative and Main Sequence Ventures as co-founding partners, the company has evolved from a consumer-focused animal-free milk effort into a B2B ingredient platform company. Its core technology replicates the natural casein micelle structure of milk — the protein complex responsible for slow-release mineral delivery — without using cows, producing a recombinant beta-casein protein (BCPP1) via microbial fermentation.
The company's commercial platform, DeepForte™, is positioned as a programmable casein micelle delivery system engineered to carry minerals such as iron, magnesium, and zinc through digestion and release them at the point of absorption. The platform offers four functional benefits: slow-release delivery for improved bioavailability, encapsulation for flavor masking and oxidation protection, high nutrient payload density, and clean-label formulation without synthetic chelators or harsh chemical carriers. Target applications span high-bioavailability supplements, fortified foods and beverages, GLP-1 companion nutrition, women's health and anaemia products, sports and performance nutrition, and engineered dairy ingredients for the broader food industry.
Eden Brew operates as a B2B ingredient supplier with a quote-based, contract-driven pricing model targeting food and supplement manufacturers in Australia and New Zealand. Revenue generation is gated by a regulatory submission to Food Standards Australia New Zealand (FSANZ) — the first such filing for a precision-fermented milk protein, with a decision expected by mid-November 2026. The company has raised approximately $23.3 million across seed and Series A funding rounds and employs 11-50 staff across protein science, fermentation, bioprocess, analytics, R&D, finance, and strategy functions.
Eden Brew firmographics
Firmographics- Name
- Eden Brew
- Legal name
- Eden Brew
- Website
- https://edenbrew.com.au
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Eden Brew is a Melbourne-based precision fermentation company producing animal-free recombinant beta-casein protein via engineered yeast. It supplies the DeepForte™ B2B casein micelle platform to food and supplement manufacturers in Australia and New Zealand for slow-release nutrient delivery.
- Ownership category
- akta.pro rank
Eden Brew industry classification
Industry- Product category
- Precision Fermentation Dairy Protein Ingredients
- NAICS
- Flavoring Syrup and Concentrate Manufacturing (311930)
- SIC
- Food And Kindred Products (2000)
- akta.pro primary industry
- Sports/Energy/Functional Concentrate Premixes (electrolyte, caffeine, vitamin bases) (AFAFAGAG)
- akta.pro secondary industry
- Functional/Fortified Beverage Production (Vitamins, Botanicals, Nootropics) (AFAFABAH)
Keywords
Where Eden Brew is headquartered
LocationHeadquarters
- HQ city
- Sydney
- HQ country
- Australia
- HQ region
- Oceania
Offices1 record
Markets served
Eden Brew business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales
Revenue model
- B2B Ingredient Sales: Selling DeepForte™ casein protein ingredients to food and supplement manufacturers. Target applications include high-bioavailability supplements, fortified foods and beverages, GLP-1 companion nutrition, women's health and anaemia products, and sports nutrition. Revenue model focuses on ingredient supply to manufacturers rather than direct consumer products.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Quote-based B2B ingredient pricing for DeepForte™ platform |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
Eden Brew product offering
Product offeringCore offering
Eden Brew develops and supplies DeepForte™, a programmable casein micelle nutrition delivery platform, and BCPP1, a recombinant beta-casein protein produced via precision fermentation using engineered yeast. The company sells these B2B ingredient solutions to food and supplement manufacturers for applications including high-bioavailability supplements, fortified foods and beverages, GLP-1 companion nutrition, women's health products, and sports nutrition.
Product overview
Eden Brew operates as a B2B precision fermentation company offering two core offerings: the DeepForte™ platform—a programmable casein micelle technology for slow-release nutrient delivery—and BCPP1, a recombinant beta-casein protein ingredient produced via microbial fermentation using engineered yeast. DeepForte™ functions as the delivery technology that enables BCPP1 to carry minerals like iron, magnesium, and zinc, while BCPP1 serves as the foundational animal-free protein ingredient. The platform targets high-value markets including supplements, sports nutrition, GLP-1 companion nutrition, women's health, and fortified foods and beverages.
Differentiator
Problem solved
Functional benefit
Brands
- DeepForte: A programmable casein micelle platform designed for slow-release nutrient delivery, enabling encapsulation, nutrient density, and clean label formulations for supplements, fortified foods, and GLP-1 companion nutrition.
Products and services
- DeepForte™ A programmable casein micelle nutrition delivery platform that replicates natural milk digestion processes. Enables slow-release nutrient delivery with improved bioavailability for iron, magnesium, zinc, and other minerals; supports encapsulation for flavor masking and oxidation protection; and offers clean-label positioning without synthetic chelators. Sold as a B2B ingredient platform to food and supplement manufacturers.
- BCPP1 (Beta-Casein Protein Preparation) Recombinant beta-casein protein produced via microbial fermentation using engineered yeast. Designed as an animal-free dairy protein ingredient for use in supplements, food fortification, sports nutrition, and GLP-1 companion nutrition applications.
Quantifiable outcome
- 70% fewer emissions compared to conventional dairy
- +3 more outcomes
Companies that use Eden Brew
Customer profileSegments6 records
Ideal customer profiles1 record
Eden Brew technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
Eden Brew partnerships and signals
Strategic signalScale indicators5 records
Recent moves6 records
Expansion highlights6 records
Eden Brew competitors and assessment
Company assessmentDirect peers
- Perfect Day: US-based precision fermentation dairy protein pioneer producing animal-free whey and casein via engineered microbes. Direct competitor to Eden Brew in B2B casein ingredient supply, with significantly more capital raised, existing FDA self-GRAS status, and partnerships with Nestlé and Mars.
- Remilk: Israel-based precision fermentation company producing animal-free milk proteins (including casein) for B2B food and beverage applications. Operates in the same core category as Eden Brew with a similar precision fermentation thesis targeting food manufacturers.
- Imagindairy: Israel-based precision fermentation startup producing animal-free dairy proteins (casein and whey) specifically for B2B food and beverage ingredient applications. Closely aligned with Eden Brew's pivot to a B2B ingredient platform.
- Daisy Lab: New Zealand-based precision fermentation startup producing animal-free dairy proteins via engineered yeast. Direct geographic and technology peer to Eden Brew, both leveraging Southern Hemisphere dairy science ecosystems (CSIRO counterpart, AgResearch).
- Bon Vivant: France-based precision fermentation company developing animal-free casein and whey proteins for B2B food industry applications. Comparable technology stack and B2B go-to-market to Eden Brew's DeepForte™.
- Vivici: Netherlands-based precision fermentation B2B ingredient company producing animal-free dairy proteins, founded by dairy industry incumbents (FrieslandCampina, DSM-firmenich). Direct competitor to Eden Brew in the B2B casein ingredient space, with stronger industrial backing.
Emerging players
- Opalia: Canada-based precision fermentation startup producing animal-free dairy proteins via engineered yeast. Emerging direct competitor with a similar technology and B2B ingredients focus, though at an earlier stage than Eden Brew.
- Helaina: US precision fermentation company producing functional proteins (initially human lactoferrin) for nutrition applications using engineered yeast. Comparable technology platform and B2B ingredient model, focused on bioactives rather than bulk casein.
- Zero Cow Factory: India-based precision fermentation startup producing animal-free milk proteins including casein. Uses a similar precision fermentation approach and targets B2B dairy ingredient applications in Asia.
- TurtleTree: Singapore/US precision fermentation company producing functional dairy proteins (including lactoferrin and casein ingredients) for nutrition applications. Comparable precision fermentation B2B ingredients model with a focus on premium nutrition verticals.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks7 records
Key highlights7 records
Customer concentration
Eden Brew social profiles
Digital presenceEden Brew financial estimates
Financial estimateRevenue estimate
Valuation estimate
Eden Brew leadership team
Management profileNumber of profiles
Profiles11 records
Eden Brew funding detail
Funding detailFunding overview
Funding rounds3 records
Investors10 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Eden Brew M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Eden Brew
What does Eden Brew do?
Eden Brew develops and supplies DeepForte™, a programmable casein micelle nutrition delivery platform, and BCPP1, a recombinant beta-casein protein produced via precision fermentation using engineered yeast. The company sells these B2B ingredient solutions to food and supplement manufacturers for applications including high-bioavailability supplements, fortified foods and beverages, GLP-1 companion nutrition, women's health products, and sports nutrition.
Is Eden Brew a public or private company?
Eden Brew is a private company. It is classified as venture growth investor backed and is currently operating.
When was Eden Brew founded?
Eden Brew was founded in 2021. It employs 11 to 50 people.
Where is Eden Brew based?
Eden Brew is headquartered in Sydney, Australia, in the Oceania region.
How does Eden Brew make money?
One revenue line is on record: B2B Ingredient Sales.
Who are Eden Brew's main competitors?
Direct peers on record are Perfect Day, Remilk, Imagindairy, Daisy Lab, Bon Vivant and Vivici. Emerging players are Opalia, Helaina, Zero Cow Factory and TurtleTree.
Does Eden Brew have an API?
No public API is recorded for Eden Brew.
What industry is Eden Brew in?
Eden Brew's product category is Precision Fermentation Dairy Protein Ingredients. Its primary akta.pro industry code is AFAFAGAG, Sports/Energy/Functional Concentrate Premixes (electrolyte, caffeine, vitamin bases), with a secondary code of AFAFABAH, Functional/Fortified Beverage Production (Vitamins, Botanicals, Nootropics). Its NAICS code is 311930 and its SIC code is 2000.